Skip to main content

Child Neurology Residency - Research

Research experiences

Research is an important part of the training of Child Neurology residents at Children’s Mercy. Training in research starts with the research mentor that each resident is encouraged to engage at the beginning of their child neurology training. The residents are also invited to complete a course on biostatistics and each resident is expected to complete a 1-year course in Quality Improvement and Clinical Safety.


As part of the QI course, each resident will initiate a QI project which can be presented at CMH Research Day. Each resident is also given the opportunity to present at the yearly Missouri Valley Child Neurology Colloquium. This is a joint meeting with The University of Washington and Saint Louis University Child Neurology programs.

Finally, each resident is expected to graduate with at least one first author publication. Over the last 4 years, our residents have given over 100 talks (with approximately 20% of these original research or case presentations) and have published 13 papers in peer reviewed journals (including original research and review papers).

View Child Neurology faculty research.

View Child Neurology resident research.

Basic neuroscience track

Special consideration can be given to a candidate who is interested in pursuing a research-based career in child neurology through the basic science track. The residency is structured slightly differently from the categorical track. The resident will have one year of general pediatrics followed by one year of adult neurology and two years of child neurology. The last year will be dedicated to research. The resident will have access to collaborations both at the University of Kansas and the University of Missouri, Kansas City. If a candidate is interested in this track they must indicate this at the time of interview.

Child Neurology Resident Program: Peer-reviewed publications


Class of 2018

Julio Quezada, MD

  1. Asturias EJ, Corral JE, Quezada J: Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. Curr Oncol Apr 2010; 17(2):59.63.
  2. Corral JE, Lima S, Quezada J, Samayoa B, Arathoon E: Cryptococcal osteomyelitis of the skull. Med Mycol Aug 2011; 49(6):667-651.
  3. Quezada J, Coffman K: Current approaches and new developments in the pharmacological management of Tourette Syndrome. CNS Drugs Jan 2018; 32(1):33-45.

Deepti Nagesh, MD

  1. Nagesh D, Goeden M, Coffman KA: Pediatric latrogenic movement disorders. Semin Pediatr Neurol Apr 2018; 25:113-122.

Class of 2017

Marcie Goeden, MD

  1. Nagesh D, Goeden M, Coffman KA: Pediatric latrogenic movement disorders. Semin Pediatr Neurol Apr 2018; 25:113-122.
  2. Goeden M, Bansal LR: Subclinical rhythmic EEG discharge of Adult (SREDA) in a child with generalized epilepsy and literature review of SREDA in children. J Clin Neurophysiol May 2018; 35(3):270-272.
  3. Albadareen R, Gronseth G, Goeden M, Sharrock M, Lechtenberg C, Wang Y: Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort. J Neurosci Jun 2017; 127(6):531-538.

Class of 2016

Britton Zuccarelli, MD

  1. Pop A, Williams M, Struys EA, Monne M, Jansen EEW, De Grassi A, Kanhai WA, Scarcia P, Ojeda MRF, Porcelli V, van Dooren SJM, Lennertz P, Nota B, Abdenur JE, Coman D, Das AM, El-Charbawy A, Nuoffer JM, Polic B, Santer R, Weinhold N, Zuccarelli B, Palmieri F, Palmieri L, Salomons GS: An overview of combined D-2- and L-2-hydroxyglutaric aciduria: function analysis of CIC variants. J Inherit Metab Dis Mar 2018; 41(2):169-180.
  2. Zuccarelli B, Coffman KA: Reducing after-hours prescription refill requests. Neurol Clin Pract Oct 2016; 6(5):429-432.
  3. Zuccarelli BD, Hall AS: Utility of obtaining a serum basic metabolic panel in the setting of a first-time nonfebrile seizure. Clinc Pediatr (Phila) Jun 2016; 55(7):650-653.
  4. Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, Le Pichon JB, Muller NA, Thiffault I, Dinwiddie DL Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zurarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF: Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med Dec 2014; 6(265):265ra168.
  5. Zuccarelli BD, Heshmati A: Exaggerated startle. Pediatr Neurol Jan; 54:97-98.
  6. Thiffault I, Zuccarelli B, Welsh H, Yuan X, Farrow E, Zellmer L, Miller N, Soden S, Abdelmoity A, Brodsky RA, Saunders C: Hypotonia and intellectual disability without dysmorphic features in a patient with PIGN-related disease. BMC Med Genet Nov 2017; 18(1):124.
  7. Zucarrelli B, Aalbers B, Grabb P: Hemiballismus as a complication of an intratumoral chemotherapy catheter. J Clin Neurosci Aug 2016; 30:129-131.

Class of 2015

Tyler Allison, MD

  1. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN, Nigro MA, Parke JT, Stumpf DA, Verhulst SJ: B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 2004; 62(9):1526-1532.
  2. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ: CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. MOV Disord 2004; 19(7):770-777.
  3. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Lee ND, Fisher J, Jasty R: Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus. J Pediatr Hematol Oncol 2004; 26(11):718-723.
  4. Pranzatelli MR, Hyland K, Tate ED, Arnold LA, Allison TJ, Soori GS: Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin. J Child Neurol 2004; 19:919-924.
  5. Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ: Neuroepidemiologic trends in 105 U.S. cases of pediatric opsoclonus-myoclonus. J Pediatr Oncol Nurs 2005; 22(1):8-19.
  6. Pranzatelli MR, Chun KY, Moxness M, Tate ED, Allison TJ: Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy. Pediatr Neurol 2005; 33:121-126.
  7. Allison T, Roncero I, Forsyth R, Coffman K, & Le Pichon, JB: Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders. J Child Neurol May 2017; 6:528–532.
  8. Pranzatelli MR, Tate ED, Allison TJ: Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers. Cytokine August 2017; 96:49–53.
  9. Pranzatelli MR, Tate, ED, Allison TJ: 6-mercaptopurine modifies cerebrospinal fluid T cell abnormalities in paediatric opsoclonus-myoclonus as steroid sparer. Clin Exp Immunol November 2017; 190(2):217-225.
  10. Pranzatelli MR, Allison TJ, McGee NR, Tate ED: Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and on-inflammatory neurologic disorders. Clin Exp Immunol July 2018; 193(1):102-112.
  11. Pranzatelli M, Tate E, Allison T: Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: a retrospective pilot study. Eur J Paediatr Neurol July 2018; 22(4):586-594.